CClinicalTrials.gg
CompletedNCT03972423TC-IRCUpdated Jul 16, 2026

Impact of a Transmission Checklist in Post Anesthesia Care Unit on Immediate Respiratory Complications

An observational study in Anesthesia, Postoperative Complications and Anesthesia Complication, sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-16.

Sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
560
Ages
18 Years and older
Sex
All
01

Study summary

This work highlighted the beneficial role in terms of carers' satisfaction, quantity and quality of information transmitted.

Read the detailed description

Communication and information transmission problems are responsible for the majority of serious adverse events. The use of a checklist in the operating theatre has demonstrated its benefit in terms of reducing morbidity and mortality Regarding transmissions between caregivers, numerous studies have shown the great difference between the medical data of a patient in their file and the information transmitted.

The authors recommend using checklists in order to standardise transmissions. This work highlighted the beneficial role in terms of carers' satisfaction, quantity and quality of information transmitted. On the other hand, no study has looked at the reduction of immediate postoperative complications in post anaesthesia care units (PACU).

02

Conditions studied

  • Anesthesia
  • Postoperative Complications
  • Anesthesia Complication

Keywords

  • checklist
  • postoperative complication
  • anesthesia
  • information transmission
  • care unit
03

In context

Postoperative Complications

1,233 studies on the registry are indexed under Postoperative Complications; 292 are open to participants now.

This study's enrollment of 560 is above the median of 254 across 519 observational studies indexed under Postoperative Complications.

Browse Postoperative Complications studies →

Lead sponsor

GCS Ramsay Santé pour l'Enseignement et la Recherche is the lead sponsor of 198 studies on the registry; 94 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

adult patients admitted to PACU

Inclusion criteria

  • Male or Female over 18 admitted to PACU
  • Patient having understood the aims and the methods of the research

    • Patient having expressed their consent to the use of their data.
    • Subject registered with or beneficiary of a social security scheme

Exclusion criteria

Exclusion Criteria:

  • Patient participating in another clinical study
  • Acute or chronic respiratory insufficiency preoperatively
  • Protected patient: adult under guardianship, tutorship or other legal protection, deprived of liberty by judicial or administrative decision
  • Pregnant or lactating women
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
560 participants (actual)
Target follow-up
12 Months
Patient registry
Yes

Groups and cohorts

  • IRCTC group

    \- The IRCTC group, consisting of all patients included in the 3rd phase of the study and for whom the transmission of information in PACU is carried out using the IRCTC.

    Other: With or wiyhout a checklist

  • CONTROL group

    \- The CONTROL group, consisting of all patients included in the 1st phase of the study and for whom the transmission of information in PACU is carried out according to the usual practice.

    Other: With or wiyhout a checklist

Interventions

  • OtherWith or wiyhout a checklist

    The evaluation of the impact of the use of this Checklist will be done in comparison with the standard transmission practice

06

What researchers measure

Primary outcomes

  1. arterial oxygen desaturation < 90%

    The primary endpoint is defined as the occurrence or not of arterial oxygen desaturation \< 90% for more than 15 consecutive seconds in PACU.

    Time frame: event of at least 15 second duration

07

Study locations

1 site
  • Les Franciscaines Clinic
    Versailles, IDF 78000, France
08

References and documents

Publications

  • Jaulin F, Lopes T, Martin F. Standardised handover process with checklist improves quality and safety of care in the postanaesthesia care unit: the Postanaesthesia Team Handover trial. Br J Anaesth. 2021 Dec;127(6):962-970. doi: 10.1016/j.bja.2021.07.002. Epub 2021 Aug 5. PubMed 34364652 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03972423
Lead sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche
Collaborators
Dr. Frédéric MARTIN
Responsible party
Sponsor
First posted
Jun 3, 2019
Start date
Feb 18, 2019
Primary completion
Feb 18, 2019
Completion
Jul 7, 2020
Last update
Jul 16, 2026

Study contacts

Frederic Martin
principal investigator · Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion